Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB–D melanoma: a phase 12 trial

unknow

★ 5.0 · 51 reads

Request Code
ZLIB.IO18491056
Published
2022
Pages
1
Language
Unknown